Personalis, Inc. - Common Stock (NQ:PSNL)

16.80 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2026 Add to My Watchlist

Price and Volume

Volume	769
Open	16.80
Bid (Size)	16.50 (100)
Ask (Size)	16.75 (300)
Prev. Close	16.80
Today's Range	16.80 - 16.80
52wk Range	4.652 - 18.89
Shares Outstanding	48,518,901
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Halper Sadeh LLC is Investigating Whether UTZ, PSNL, DSGR are Obtaining Fair Deals for their Shareholders

August 07, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Personalis Reports Second Quarter Results and Recent Highlights

August 04, 2026

From Personalis, Inc.

Via Business Wire

Performance

YTD	+114.0%	+114.0%
1 Month	+41.4%	+41.4%
3 Month	+53.0%	+53.0%
6 Month	+86.0%	+86.0%
1 Year	+251.5%	+251.5%

More News

Halper Sadeh LLC is Investigating Whether UTZ, BLFS, FNWD, PSNL are Obtaining Fair Deals for their Shareholders

July 30, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether FNWD and PSNL are Obtaining Fair Deals for their Shareholders

July 29, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether LXP, FNWD, PSNL are Obtaining Fair Deals for their Shareholders

July 28, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Personalis (NASDAQ:PSNL) Volume Surge Can't Mask Q1 Miss as Losses Widen ↗

May 07, 2026

Via Chartmill

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Luxfer Holdings PLC (NYSE – LXFR), Finward Bancorp (Nasdaq – FNWD), Personalis, Inc. (Nasdaq – PSNL), Distribution Solutions Group, Inc. (Nasdaq – DSGR)

July 27, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether UTZ, PSNL, LXP are Obtaining Fair Deals for their Shareholders

July 22, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Personalis Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Personalis, Inc. - PSNL

July 21, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Distribution Solutions Group, Inc. (Nasdaq – DSGR), Cross Country Healthcare, Inc. (Nasdaq – CCRN), Nuvalent, Inc. (Nasdaq – NUVL)

July 21, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

PSNL Stock Alert: Halper Sadeh LLC is Investigating Whether Personalis, Inc. is Obtaining a Fair Price for Shareholders

July 20, 2026

From Halper Sadeh LLC

Via Business Wire

Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform

July 20, 2026

From Personalis, Inc.

Via Business Wire

Personalis Accelerates Global Expansion with UKCA Marking for NeXT Personal®, Expanding MRD Access and Biopharma Support in Great Britain

July 14, 2026

From Personalis, Inc.

Via Business Wire

Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits

June 09, 2026

From Personalis, Inc.

Via Business Wire

Personalis CEO Sells 100,000 Company Shares Worth $1.1 Million. What Does That Mean for Investors? ↗

June 04, 2026

Via The Motley Fool

Personalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types at ASCO 2026

June 02, 2026

From Personalis, Inc.

Via Business Wire

Personalis to Highlight Breadth of NeXT Personal® Ultra-Sensitive ctDNA Data at ASCO 2026 Annual Meeting, Including Podium Presentation from TRACERx Consortium

May 26, 2026

From Personalis, Inc.

Via Business Wire

Personalis Secures Fourth Medicare Coverage Decision for NeXT Personal®, Expanding Breast Cancer Coverage to Pre-Surgical Treatment Monitoring

May 20, 2026

From Personalis, Inc.

Via Business Wire

Personalis to Participate in Upcoming Investor Events

May 14, 2026

From Personalis, Inc.

Via Business Wire

Personalis Receives Medicare Coverage for NeXT Personal® for Immunotherapy Monitoring Across Late-stage Solid Tumors

May 13, 2026

From Personalis, Inc.

Via Business Wire

Personalis Q1 Earnings Call Highlights ↗

May 08, 2026

Via MarketBeat

Personalis (PSNL) Q1 2026 Earnings Transcript ↗

May 08, 2026

Via The Motley Fool

Personalis Reports First Quarter Results and Recent Highlights

May 07, 2026

From Personalis, Inc.

Via Business Wire

Personalis to Announce First Quarter 2026 Financial Results

April 23, 2026

From Personalis, Inc.

Via Business Wire

Personalis Highlights Clinical Impact of Ultrasensitive ctDNA Monitoring and New Therapy Resistance Tracking at AACR 2026

April 21, 2026

From Personalis, Inc.

Via Business Wire

Frequently Asked Questions

Is Personalis, Inc. - Common Stock publicly traded?

Yes, Personalis, Inc. - Common Stock is publicly traded.

What exchange does Personalis, Inc. - Common Stock trade on?

Personalis, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Personalis, Inc. - Common Stock?

The ticker symbol for Personalis, Inc. - Common Stock is PSNL on the Nasdaq Stock Market

What is the current price of Personalis, Inc. - Common Stock?

The current price of Personalis, Inc. - Common Stock is 16.80

When was Personalis, Inc. - Common Stock last traded?

The last trade of Personalis, Inc. - Common Stock was at 08/27/26 04:00 PM ET

What is the market capitalization of Personalis, Inc. - Common Stock?

The market capitalization of Personalis, Inc. - Common Stock is 815.12M

How many shares of Personalis, Inc. - Common Stock are outstanding?

Personalis, Inc. - Common Stock has 815M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.